Generics manufacturer Apotex files lawsuit against Health Canada over import banBMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g7380 (Published 01 December 2014) Cite this as: BMJ 2014;349:g7380
- Owen Dyer
Canada’s health ministry and the country’s largest manufacturer of generic drugs, Apotex, long accused of an overly cosy relationship, are locked in a bitter legal battle after the Canadian health minister, Rona Ambrose, banned the import of all drugs and ingredients made in two Apotex plants in Bangalore, India.
Health Canada twice asked Apotex to halt imports from one plant over quality concerns, but the company refused. The minister then banned the products and said that trust between the regulator and the manufacturer had been “broken.” Apotex responded with a lawsuit alleging that Health Canada had acted with “malice” and had folded to pressure from the media and the opposition. “The minister’s decision to implement the import ban was politically motivated and, in particular, was calculated to deflect public and parliamentary criticism of the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial